Organization | Government of Norway

Government of Norway Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4

Founded: Oslo Norway (1884)

Organization Overview

First Clinical Trial

1998

NCT00266487

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

City of Oslo, Norway | Department of Physical Performance, Norwegian School of Sports Science | Folkehelsa | Norwegian Council for Mental Health | Norwegian Defense Research Establishment | Norwegian Department of Health and Social Affairs | Norwegian Directorate of Health | Norwegian Institute of Public Health | Norwegian Labour and Welfare Administration | Norwegian ministry of Education and Research | Norwegian School of School of Sport Sciences | The Norwegian Directorate for Education and Training | The Norwegian Doping Control Laboratory | The Norwegian Institute of Food, Fisheries and Aquaculture research (NOFIMA) | The Norwegian National Advisory Unit on Ageing and Health | The Norwegian School of Sport Sciences | The Research Council of Norway | The Royal Norwegian Ministry of Health

Active Ingredients

Drugs in Phase 4 Trials (18)

amoxicillin (1 trial)

beclomethasone (vanceril) (1 trial)

cod liver oil (1 trial)

cycloserine (seromycin) (1 trial)

doxycycline (vibramycin) (1 trial)

hepatitis b vaccine (recombinant) (Recombivax) (1 trial)

hepatitis e vaccine (1 trial)

Inactivated polio virus - Enhanced (IPOL) (1 trial)

methylphenidate (ritalin) (1 trial)

metronidazole (flagyl) (1 trial)

phenoxymethylpenicillin (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (1 trial)

rimabotulinumtoxinB (Myobloc) (2 trials)

technetium tc-99m pentetate kit (renotec) (1 trial)

triamcinolone (kenalog) (1 trial)

vitamin d3 (2 trials)

Drugs in Phase 3 Trials (20)

acetaminophen (tylenol) (1 trial)

alteplase (Activase) (1 trial)

buprenorphine (2 trials)

cyanocobalamin (berocca) (2 trials)

dihydroartemisinin (2 trials)

flecainide (tambocor) (1 trial)

folic acid (2 trials)

lamivudine (epivir) (1 trial)

lopinavir (Kaletra) (1 trial)

metoprolol (lopressor) (1 trial)

morphine (1 trial)

naloxone (narcan) (1 trial)

naltrexone (revia) (2 trials)

piperaquine (2 trials)

pregabalin (lyrica) (1 trial)

pyridoxine (2 trials)

ritonavir (Norvir) (1 trial)

rituximab (rituxan) (1 trial)

tenecteplase (tnkase) (2 trials)

thalidomide (Thalomid) (1 trial)

Drugs in Phase 2 Trials (28)

acetylsalicylic acid (aspirin) (1 trial)

adjuvanted flu-v (1 trial)

afatinib (gilotrif) (1 trial)

dabrafenib (tafinlar) (1 trial)

empagliflozin (jardiance) (1 trial)

etoricoxib (Gencox) (1 trial)

everolimus (zortress) (1 trial)

fatty acid (1 trial)

fluarix (1 trial)

human fecal microbiota (Reybota) (1 trial)

linagliptin (tradjenta) (1 trial)

metformin (glucophage) (1 trial)

methadone (methadose) (1 trial)

nilotinib (tasigna) (1 trial)

pioglitazone (actos) (1 trial)

pomegranate (1 trial)

ruxolitinib (jakafi) (1 trial)

selenium (1 trial)

ser100 (1 trial)

soybean (1 trial)

sunitinib (sutent) (1 trial)

temsirolimus (torisel) (1 trial)

thiamine (1 trial)

tomato (1 trial)

vandetanib (caprelsa) (1 trial)

vemurafenib (zelboraf) (1 trial)

vitis vinifera (1 trial)

Drugs in Phase 1 Trials (4)

calcium (1 trial)

calcium carbonate (1 trial)

menpf-1 (1 trial)

seal oil (1 trial)

Drugs in Other Trials (13)

beta-glucans (1 trial)

butter (1 trial)

cod protein (2 trials)

cow milk (1 trial)

essential amino acids (1 trial)

ethanol (2 trials)

fish oil (Omegavan) (1 trial)

lactobacillus reuteri (1 trial)

lactobacillus rhamnosus (1 trial)

multivitamins (1 trial)

whey protein (2 trials)

zopiclone (Zimovane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anemia (Phase 3)

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Avitaminosis (Phase 4)

Back Pain (Phase 1)

Brain Diseases (Phase 3)

Cerebral Infarction (Phase 3)

Cerebral Palsy (Phase 4)

Colorectal Neoplasms (Phase 2)

Compulsive Personality Disorder (Phase 4)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Dementia (Phase 3)

Diabetes Mellitus, Type 1 (Phase 2)

Digestive System Diseases (Phase 4)

Diphtheria (Phase 4)

Encephalitis (Phase 3)

Encephalomyelitis (Phase 2)

Erythema (Phase 4)

Erythema Chronicum Migrans (Phase 4)

Fatigue (Phase 3)

Fatigue Syndrome, Chronic (Phase 3)

Gastrointestinal Diseases (Phase 4)

Glossitis, Benign Migratory (Phase 4)

Glucose Intolerance (Phase 2)

Glucose Metabolism Disorders (Phase 2)

Headache (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis E (Phase 4)

HIV Infections (Phase 3)

Hyperkinesis (Phase 4)

Hypersensitivity (Phase 2)

Hypertension (Phase 2)

Infarction (Phase 3)

Infections (Phase 4)

Influenza, Human (Phase 2)

Insulin Resistance (Phase 2)

Ischemia (Phase 3)

Liver Neoplasms (Phase 2)

Low Back Pain (Phase 1)

Lyme Disease (Phase 4)

Malaria (Phase 3)

Meningitis (Phase 4)

Meningitis, Meningococcal (Phase 4)

Meningococcal Infections (Phase 4)

Metabolic Diseases (Phase 2)

Multiple Myeloma (Phase 3)

Musculoskeletal Pain (Phase 4)

Myalgia (Phase 3)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Neoplasms, Second Primary (Phase 2)

Obsessive-Compulsive Disorder (Phase 4)

Opioid-Related Disorders (Phase 3)

Paralysis (Phase 4)

Periodontal Diseases (Phase 4)

Pneumonia (Phase 4)

Poliomyelitis (Phase 4)

Prostatic Neoplasms (Phase 2)

Psychomotor Agitation (Phase 3)

Respiratory Tract Infections (Phase 4)

Stroke (Phase 3)

Syndrome (Phase 3)

Tetanus (Phase 4)

Tetany (Phase 4)

Whooping Cough (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 52
# of Trial APIs: 83